Birgitta A R Schmidt, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nevus, Epithelioid and Spindle Cell | 4 | 2022 | 67 | 0.990 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.770 |
Why?
|
| Subcutaneous Tissue | 1 | 2021 | 131 | 0.740 |
Why?
|
| Nevus, Pigmented | 2 | 2022 | 222 | 0.720 |
Why?
|
| Hemangioma | 1 | 2021 | 727 | 0.540 |
Why?
|
| Skin Neoplasms | 8 | 2022 | 5859 | 0.370 |
Why?
|
| Pemphigus | 2 | 2020 | 107 | 0.290 |
Why?
|
| Molluscum Contagiosum | 2 | 2020 | 15 | 0.280 |
Why?
|
| Melanoma | 5 | 2022 | 5702 | 0.270 |
Why?
|
| Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.220 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2024 | 491 | 0.210 |
Why?
|
| Sweet Syndrome | 1 | 2023 | 56 | 0.210 |
Why?
|
| Lipoxins | 5 | 2007 | 419 | 0.200 |
Why?
|
| Drug Eruptions | 2 | 2024 | 335 | 0.180 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 2012 | 169 | 0.180 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 914 | 0.160 |
Why?
|
| Ketorolac | 1 | 2019 | 95 | 0.150 |
Why?
|
| Epoxide Hydrolases | 1 | 2019 | 122 | 0.150 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.150 |
Why?
|
| Skin Diseases, Genetic | 1 | 2018 | 49 | 0.140 |
Why?
|
| Dermatitis Herpetiformis | 1 | 2017 | 22 | 0.140 |
Why?
|
| Fibroma | 2 | 2009 | 196 | 0.140 |
Why?
|
| Skin | 4 | 2024 | 4499 | 0.140 |
Why?
|
| Dapsone | 1 | 2017 | 55 | 0.140 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 319 | 0.140 |
Why?
|
| Skin Diseases | 3 | 2014 | 1083 | 0.140 |
Why?
|
| Erythema | 1 | 2018 | 261 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 597 | 0.130 |
Why?
|
| Skin Transplantation | 3 | 2011 | 1097 | 0.130 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2015 | 15 | 0.120 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 998 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1228 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 1560 | 0.110 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2022 | 2428 | 0.100 |
Why?
|
| Immune System Diseases | 1 | 2015 | 253 | 0.100 |
Why?
|
| Receptors, Lipoxin | 2 | 2003 | 83 | 0.100 |
Why?
|
| Ear, External | 2 | 2011 | 165 | 0.100 |
Why?
|
| Child, Preschool | 12 | 2021 | 42606 | 0.100 |
Why?
|
| Receptors, Formyl Peptide | 2 | 2003 | 146 | 0.100 |
Why?
|
| Purpura | 1 | 2012 | 117 | 0.100 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 2 | 2003 | 225 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2003 | 299 | 0.090 |
Why?
|
| Pilomatrixoma | 1 | 2011 | 24 | 0.090 |
Why?
|
| Leukemia | 1 | 2019 | 1518 | 0.090 |
Why?
|
| Hair Diseases | 1 | 2011 | 72 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2019 | 2252 | 0.090 |
Why?
|
| Desiccation | 1 | 2010 | 77 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 986 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4522 | 0.080 |
Why?
|
| Erythema Multiforme | 1 | 2009 | 31 | 0.080 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2009 | 40 | 0.080 |
Why?
|
| Aconitine | 1 | 2008 | 3 | 0.080 |
Why?
|
| Ear Diseases | 1 | 2011 | 181 | 0.080 |
Why?
|
| Nose Neoplasms | 1 | 2011 | 250 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2441 | 0.080 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2008 | 58 | 0.080 |
Why?
|
| Oral Ulcer | 1 | 2009 | 95 | 0.080 |
Why?
|
| Lipomatosis | 1 | 2009 | 112 | 0.080 |
Why?
|
| Syndactyly | 1 | 2008 | 75 | 0.070 |
Why?
|
| Diarrhea | 1 | 2015 | 1319 | 0.070 |
Why?
|
| Diagnosis, Differential | 9 | 2017 | 12986 | 0.070 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 518 | 0.070 |
Why?
|
| Child | 8 | 2022 | 80771 | 0.070 |
Why?
|
| Nevus, Blue | 1 | 2008 | 43 | 0.070 |
Why?
|
| Melanocytes | 1 | 2011 | 509 | 0.070 |
Why?
|
| Toes | 1 | 2008 | 209 | 0.070 |
Why?
|
| Nevus | 1 | 2009 | 205 | 0.070 |
Why?
|
| Phenyl Ethers | 1 | 2007 | 62 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2007 | 2270 | 0.060 |
Why?
|
| Genomics | 1 | 2022 | 5924 | 0.060 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 271 | 0.060 |
Why?
|
| Fingers | 1 | 2008 | 508 | 0.060 |
Why?
|
| Host vs Graft Reaction | 1 | 2005 | 13 | 0.060 |
Why?
|
| Arthralgia | 1 | 2009 | 459 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2014 | 2926 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 1240 | 0.060 |
Why?
|
| Analgesia | 1 | 2008 | 461 | 0.060 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2009 | 565 | 0.060 |
Why?
|
| Neutropenia | 1 | 2009 | 892 | 0.060 |
Why?
|
| Cytokines | 1 | 2019 | 7446 | 0.050 |
Why?
|
| Graft vs Host Disease | 2 | 2014 | 3049 | 0.050 |
Why?
|
| Adolescent | 9 | 2021 | 89046 | 0.050 |
Why?
|
| Vascular Malformations | 1 | 2009 | 469 | 0.050 |
Why?
|
| Biomimetic Materials | 1 | 2005 | 170 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 1396 | 0.050 |
Why?
|
| Eicosanoids | 1 | 2005 | 284 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2011 | 916 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9410 | 0.050 |
Why?
|
| Bone Marrow Transplantation | 2 | 2015 | 2710 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2416 | 0.050 |
Why?
|
| Genital Neoplasms, Female | 1 | 2008 | 535 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4903 | 0.050 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2024 | 231 | 0.050 |
Why?
|
| Bronchitis | 1 | 2002 | 193 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10254 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2008 | 1005 | 0.050 |
Why?
|
| Fever | 1 | 2009 | 1605 | 0.050 |
Why?
|
| Humans | 25 | 2024 | 767040 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 9245 | 0.050 |
Why?
|
| Male | 19 | 2024 | 364203 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2011 | 2627 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2009 | 1162 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2012 | 4209 | 0.040 |
Why?
|
| Female | 16 | 2024 | 396660 | 0.040 |
Why?
|
| Bronchi | 1 | 2003 | 847 | 0.040 |
Why?
|
| Wound Healing | 1 | 2010 | 2800 | 0.040 |
Why?
|
| Mice | 9 | 2024 | 81912 | 0.040 |
Why?
|
| Platinum | 1 | 2019 | 219 | 0.040 |
Why?
|
| Eosinophils | 2 | 2018 | 951 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 1801 | 0.040 |
Why?
|
| Adult | 7 | 2024 | 223317 | 0.030 |
Why?
|
| Neutrophils | 2 | 2012 | 3779 | 0.030 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2011 | 734 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2009 | 2160 | 0.030 |
Why?
|
| Peritonitis | 2 | 2012 | 368 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13650 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 4 | 2007 | 6226 | 0.030 |
Why?
|
| Taxoids | 1 | 2019 | 665 | 0.030 |
Why?
|
| Histiocytosis | 1 | 2014 | 40 | 0.030 |
Why?
|
| Animals | 11 | 2024 | 168965 | 0.030 |
Why?
|
| Aspirin | 2 | 2004 | 3135 | 0.030 |
Why?
|
| Vitiligo | 1 | 2014 | 97 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2019 | 2626 | 0.030 |
Why?
|
| Eosinophilia | 1 | 2018 | 554 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 7469 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2023 | 26396 | 0.030 |
Why?
|
| Infant | 5 | 2019 | 36485 | 0.030 |
Why?
|
| Granulocytes | 1 | 2014 | 551 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 594 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 386 | 0.020 |
Why?
|
| Microbial Viability | 1 | 2012 | 236 | 0.020 |
Why?
|
| Macrophages | 2 | 2019 | 5785 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2472 | 0.020 |
Why?
|
| Hemangioma, Capillary | 1 | 2011 | 64 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 4648 | 0.020 |
Why?
|
| Hypothermia | 1 | 2012 | 189 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7868 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 22361 | 0.020 |
Why?
|
| Cystadenocarcinoma, Papillary | 1 | 2009 | 56 | 0.020 |
Why?
|
| Basement Membrane | 1 | 2010 | 348 | 0.020 |
Why?
|
| Vancomycin | 1 | 2012 | 504 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13646 | 0.020 |
Why?
|
| Anesthetics, Combined | 1 | 2008 | 43 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 837 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4892 | 0.020 |
Why?
|
| Facial Neoplasms | 1 | 2009 | 126 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 18330 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1836 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3804 | 0.020 |
Why?
|
| Lipids | 1 | 2019 | 3322 | 0.020 |
Why?
|
| Sodium Channel Blockers | 1 | 2008 | 171 | 0.020 |
Why?
|
| Hamartoma | 1 | 2009 | 235 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 104 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2008 | 685 | 0.020 |
Why?
|
| Leukotriene Antagonists | 1 | 2007 | 124 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2014 | 2605 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2008 | 339 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 1361 | 0.020 |
Why?
|
| Receptors, Leukotriene | 1 | 2007 | 97 | 0.020 |
Why?
|
| Psoriasis | 1 | 2014 | 925 | 0.020 |
Why?
|
| Inflammation | 3 | 2019 | 10869 | 0.020 |
Why?
|
| Sulfides | 1 | 2007 | 171 | 0.020 |
Why?
|
| Scalp | 1 | 2009 | 390 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 924 | 0.020 |
Why?
|
| Acetates | 1 | 2007 | 314 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2007 | 436 | 0.020 |
Why?
|
| Leukocytes | 2 | 2005 | 2034 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2007 | 677 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 1606 | 0.020 |
Why?
|
| Lidocaine | 1 | 2008 | 545 | 0.020 |
Why?
|
| Epinephrine | 1 | 2008 | 782 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2011 | 8068 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 2118 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2008 | 655 | 0.010 |
Why?
|
| Zymosan | 1 | 2004 | 134 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 1429 | 0.010 |
Why?
|
| Medical Records | 1 | 2009 | 1409 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2019 | 14476 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11063 | 0.010 |
Why?
|
| Asthma | 1 | 2002 | 6268 | 0.010 |
Why?
|
| Receptors, Cell Surface | 2 | 2003 | 2815 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 2900 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10455 | 0.010 |
Why?
|
| Young Adult | 3 | 2019 | 59980 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3611 | 0.010 |
Why?
|
| Biopsy | 1 | 2014 | 6777 | 0.010 |
Why?
|
| Chemokine CCL11 | 1 | 2002 | 128 | 0.010 |
Why?
|
| Cicatrix | 1 | 2008 | 798 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18401 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2004 | 703 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2002 | 219 | 0.010 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 572 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1377 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4210 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 3052 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 267 | 0.010 |
Why?
|
| Quinolines | 1 | 2007 | 770 | 0.010 |
Why?
|
| Health Surveys | 1 | 2011 | 4056 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2616 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2002 | 286 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2008 | 1247 | 0.010 |
Why?
|
| Prostaglandins | 1 | 2002 | 398 | 0.010 |
Why?
|
| Lower Extremity | 1 | 2009 | 1217 | 0.010 |
Why?
|
| Leukotrienes | 1 | 2002 | 232 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3449 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2002 | 391 | 0.010 |
Why?
|
| Swine | 1 | 2010 | 5987 | 0.010 |
Why?
|
| Middle Aged | 4 | 2024 | 223233 | 0.010 |
Why?
|
| Allergens | 1 | 2007 | 1436 | 0.010 |
Why?
|
| Graft Survival | 1 | 2010 | 3896 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 39317 | 0.010 |
Why?
|
| Reperfusion Injury | 1 | 2004 | 1043 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2412 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 10748 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2004 | 4026 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 11217 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 81659 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 4838 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23621 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2004 | 1942 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5203 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14672 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 23713 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2014 | 15824 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29963 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 21526 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9551 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 18063 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20741 | 0.000 |
Why?
|
| Risk Factors | 1 | 2009 | 74886 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36582 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 171319 | 0.000 |
Why?
|